Skip to main content
HR 780 108th Congress House

Prescription Drug Price Reduction Act

Official title: To amend the Federal Food, Drug, and Cosmetic Act to provide for the implementation of the program under section 804 of such Act, and for other purposes.

Introduced: February 13, 2003 See on congress.gov
Health Administrative procedureCommerceDepartment of Health and Human ServicesDrug industry
More subjectsShow fewer subjects
DrugsForeign Trade and International FinanceGovernment Operations and PoliticsImportsLabelingLawPharmaciesPharmacistsPrescription pricingWholesale trade
Sign in to write a letter Sign in to watch
This bill died when the 108th Congress ended
It never became law before the 108th Congress (2003–2004) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 26, 2003
Referred to the Subcommittee on Health.
Feb 13, 2003
Referred to the House Committee on Energy and Commerce.
Feb 13, 2003
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action February 26, 2003

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service
Prescription Drug Price Reduction Act - Amends the Federal Food, Drug, and Cosmetic Act to repeal the condition on the permission to pharmacists and wholesalers to import prescription drugs from Canada into the United States that the Secretary first demonstrate to Congress the safety of such products and the financial benefit to consumers of permitting their importation. (Thus allows the importation of such drugs to proceed without fulfillment of prerequisites.) Repeals termination of the importation program.

Directs the Secretary to promulgate a final rule for carrying out the provisions on covered products within a year of the enactment of this Act, with the effective date for such final rule to be no later than 30 days after the date of promulgation.

Classifies an imported covered product as misbranded unless it bears labeling that identifies: (1) the country of origin; (2) the name and address of the importer; and (3) the name and address of the person who exported the product to the United States.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 6
All 6 Democratic 1 Independent 1
D
Van Hollen, Chris
Maryland · Mar 6, 2003
FROST, MARTIN
· Feb 13, 2003
HILL, BARON
· Feb 13, 2003
 I
Sanders, Bernard
Vermont · Feb 13, 2003
STENHOLM, CHARLES
· Feb 13, 2003
TURNER, JIM
· Feb 13, 2003
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 780: Prescription Drug Price Reduction Act. 108th Congress. Open America. https://openamerica.io/bill/108-HR-780/
MLA
"H.R. 780: Prescription Drug Price Reduction Act." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-HR-780/.
Bluebook (legal)
H.R. 780, 108th Cong. (2026), https://openamerica.io/bill/108-HR-780/.
Markdown link
[H.R. 780: Prescription Drug Price Reduction Act](https://openamerica.io/bill/108-HR-780/)
Report a problem